ChemicalBook >> CAS DataBase List >>icFSP1

icFSP1

CAS No.
1115910-36-5
Chemical Name:
icFSP1
Synonyms
icFSP1;Benzeneacetamide, 3,4,5-trimethoxy-N-[4-(2-methyl-4-oxo-3(4H)-quinazolinyl)phenyl]-;N-(4-(2-Methyl-4-oxoquinazolin-3(4H)-yl)phenyl)-2-(3,4,5-trimethoxyphenyl)acetamide
CBNumber:
CB813695134
Molecular Formula:
C26H25N3O5
Molecular Weight:
459.49
MDL Number:
MOL File:
1115910-36-5.mol
Last updated:2025-04-18 09:52:50

icFSP1 Properties

Density 1.251±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
storage temp. -10 to -25°C
solubility DMSO: 2mg/mL, clear
form Solid
pka 13.608±0.70(predicted)
color White to yellow
UNSPSC Code 12352200

icFSP1 Chemical Properties,Uses,Production

Uses

icFSP1 is a potent ferroptosis suppressor protein-1 (FSP1) inhibitor. icFSP1 triggers subcellular relocalization of FSP1 from the membrane and FSP1 condensation, in synergism with GPX4 inhibition. icFSP1 induces ferroptosis. icFSP1 shows antitumor activity against melanoma.[1].

Biological Activity

Selective and efficacious in vivo inhibitor of ferroptosis-suppressor-protein 1 (FSP1); ferroptosis inducer.

icFSP1 is a selective and efficacious in vivo inhibitor of ferroptosis-suppressor-protein 1 (FSP1). icFSP1 triggers subcellular relocalization of FSP1 from the membrane and initiate FSP1 reversible aggregation into liquid droplet-like structures before ferroptosis initiation. It synergizes with ferroptosis inducing agents to potentiate the ferroptotic cell death response.

in vivo

icFSP1 (50?mg/kg, i.p., twice daily) impairs tumour growth in a tumour-bearing (Gpx4 and Fsp1 double knockout B16F10 cells overexpressing hFSP1) mouse model[1].

Animal Model:Tumour-bearing (Gpx4 and Fsp1 double knockout B16F10 cells overexpressing hFSP1) mouse (C57BL/6J) model[1]
Dosage:50 mg/kg
Administration:Intraperitoneal injection (i.p.), twice daily
Result:Inhibited tumour growth and decreased tumour weight, without affecting body weight.
Increased the abundance of hFSP1 condensates and immunoreactivity to 4-hydroxynonenal (4-HNE).

References

[1] Toshitaka Nakamura, et al. Phase separation of FSP1 promotes ferroptosis. Nature. 2023 Jul;619(7969):371-377. DOI:10.1038/s41586-023-06255-6

icFSP1 Preparation Products And Raw materials

Raw materials

Preparation Products

icFSP1 Suppliers

Global( 15)Suppliers
Supplier Tel Email Country ProdList Advantage
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000 marketing@targetmol.com United States 32159 58
Shanghai Lollane Biological Technology Co.,Ltd. 021-52996696,15000506266 15000506266 China 4601 55
Tianjin Kailiqi Biotechnology Co., Ltd. 15076683720 klq@cw-bio.com China 6188 55
DC Chemicals 021-58447131 13564518121 sales@dcchemicals.com China 9409 58
Bide Pharmatech Ltd. 400-1647117 13681763483 product02@bidepharm.com China 62072 58
TargetMol Chemicals Inc. 4008200310 marketing@tsbiochem.com China 24641 58
Nantong QuanYi Biotechnology Co., Ltd 0513-66337626 18051384581 sales@chemhifuture.com China 5236 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627 customer_service@efebio.com China 11973 58
Hubei wei shi reagent group ltd., company 027-59101766 13125137661 2853877621@qq.com China 7901 58
Jiangsu Aikon Biopharmaceutical R&D Co.,Ltd 025-58851090 17714375163 2881759498@qq.com China 13012 58

View Lastest Price from icFSP1 manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
icFSP1 pictures 2024-11-19 icFSP1
1115910-36-5
US $290.00-930.00 / mg 99.12% 10g TargetMol Chemicals Inc.
  • icFSP1 pictures
  • icFSP1
    1115910-36-5
  • US $290.00-930.00 / mg
  • 99.12%
  • TargetMol Chemicals Inc.
icFSP1 N-(4-(2-Methyl-4-oxoquinazolin-3(4H)-yl)phenyl)-2-(3,4,5-trimethoxyphenyl)acetamide Benzeneacetamide, 3,4,5-trimethoxy-N-[4-(2-methyl-4-oxo-3(4H)-quinazolinyl)phenyl]- 1115910-36-5